PROGNOSTIC IMPACT OF COMMUNITY-ACQUIRED AND HOSPITAL-ACQUIRED HYPONATREMIA IN PATIENTS WITH DECOMPENSATED HEART FAILURE

QR Code

PROGNOSTIC IMPACT OF COMMUNITY-ACQUIRED AND HOSPITAL-ACQUIRED HYPONATREMIA IN PATIENTS WITH DECOMPENSATED HEART FAILURE

Aim. To compare prognostic impact of community-acquired and hospital-acquired hyponatremia in hospitalized patients with decompensated heart failure Material and methods. Data of 120 patients with decompensated heart failure were analyzed. Hyponatremia was defined as serum sodium concentration of 13...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. Yu. Shchekochikhin, Ph. Yu. Kopylov, N. L. Kozlovskaya, A. L. Syrkin
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	hyponatremia decompensation of heart failure acute cardiorenal syndrome resistance to diuretics
Online Access:	https://www.rpcardio.online/jour/article/view/301
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CLINICAL AND PROGNOSTIC VALUE OF HYPONATREMIA IN PATIENTS WITH CHRONIC HEART FAILURE
by: N. T. Vatutin, et al.
Published: (2018-10-01)

Clinico-demographic characteristics of the patients with decompensated chronic heart failure Clinico-demographic characteristics of the patients with decompensated chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (2011-04-01)

Furosemide‐hydration matching with RenalGuard® in decompensated heart failure: an alternative way to use diuretics and saline
by: Massimo Mapelli, et al.
Published: (2025-08-01)

CARDIORENAL INTERACTION IN DECOMPENSATED CHRONIC HEART FAILURE
by: Zh. D. Kobalava, et al.
Published: (2016-05-01)

Changes of natriuresis and prediction of cardiovascular events in patients with type 2 diabetes and decompensated heart failure over therapy with sodium-glucose cotransporter 2 inhibitors and standard diuretic therapy
by: O. A. Abdullaev, et al.
Published: (2024-03-01)

Respiratory Muscles Training in the Complex Treatment of Patients with Acute Decompensated Heart Failure
by: N. T. Vatutin, et al.
Published: (2022-02-01)

Prognostic value of renal function in patients with acute decompensation of chronic heart failure
by: I. A. Meray, et al.
Published: (2008-08-01)

Adding Tolvaptan in the Inpatient Treatment for Patients with Heart Failure and Hyponatremia: Budget Impact Analysis in Thailand
by: Permsuwan U, et al.
Published: (2025-07-01)

Prognostic value of acute kidney injury in patients hospitalized with acute decompensation of chronic heart failure
by: Zh. D. Kobalava, et al.
Published: (2025-07-01)

Strategy of selecting the scales of risk, prognosis, and disease severity in patients with acute decompensated heart failure
by: A. G. Arutyunov
Published: (2013-04-01)

Risk factors for acute decompensated heart failure in type 2 diabetes patients
by: N. A. Koziolova, et al.
Published: (2020-05-01)

Acute decompensated heart failure in patients with prediabetes: relationship with risk factors and comorbidities
by: N. A. Koziolova, et al.
Published: (2023-04-01)

Diuretic Therapy: Mechanisms, Clinical Applications, and Management
by: Nicoleta-Mirela Blebea, et al.
Published: (2025-05-01)

Efficacy and safety of combining a thiazide diuretic with a loop diuretic in decompensated heart failure: A systematic review and meta-analysis
by: Rodrigo Bessa, et al.
Published: (2025-08-01)

Aquaretics Use in Acute Decompensated Heart Failure (ADHF) Patients: A Literature Review
by: Norman Sukmadi, et al.
Published: (2022-09-01)

Albuminuria as a marker of systemic congestion and a predictor of poor long-term prognosis in acute decompensated heart failure
by: Zh. D. Kobalava, et al.
Published: (2024-05-01)

Hyponatremia in Parkinson’s Disease: The Impact of Carbidopa-Levodopa Therapy
by: Elizabeth Schumacher, et al.
Published: (2025-06-01)

Digital model for predicting the risk of developing acute decompensated heart failure
by: N. B. Lebedeva, et al.
Published: (2024-07-01)

Causes of development and progression of cardiorenal syndrome in heart failure patients. Prevention methods
by: V. V. Davydov, et al.
Published: (2021-02-01)

Efficacy and safety of acetazolamide in patients with NYHA class II-IV decompensated heart failure: protocol of an open-label prospective randomized multicenter study (ORION-A)
by: O. A. Rubanenko, et al.
Published: (2023-09-01)

An unexpected cause of hyponatremia in a cancer patient: Trimethoprim-sulfamethoxazole
by: Dilsa Mizrak, et al.
Published: (2016-04-01)

Practical approach to the diagnosis and therapy of hyponatremia
by: Zoltán Nádházi
Published: (2025-07-01)

Empagliflozin in patients hospitalized for acute decompensated heart failure: an expert resolution on the discussion of the EMPULSE trial
by: Yu. M. Lopatin, et al.
Published: (2022-04-01)

Factors associated with the risk of progression and decompensation of heart failure in patients with an implantable cardioverter-defibrillator
by: N. B. Lebedeva, et al.
Published: (2024-04-01)

DECOMPENSATED CHRONIC HEART FAILURE: FROM PATHOGENESIS TO PROGNOSIS
by: K. S. Fazulina
Published: (2016-12-01)

Let’s Talk LMCC (S02E02): Hyponatremia
by: Zachary Rehany, et al.
Published: (2025-06-01)

Prevalence and clinical significance of iron deficiency in patients with acute decompensated heart failure
by: E. A. Smirnova, et al.
Published: (2023-09-01)

Fatal Pontine and Extrapontine Myelinolysis after Severe Hyponatremia Correction: A Case Report
by: Erika Jokubauskaitė, et al.
Published: (2024-12-01)

Organoprotective effects of serelaxin in patients with severe decompensated heart failure
by: Z. D. Kobalava, et al.
Published: (2016-09-01)

Natriuresis as a Way to Assess the Effectiveness of Diuretic Therapy for Acute Decompensated Heart Failure: Data from a Pilot Study
by: K. V. Charaya, et al.
Published: (2023-01-01)

PREDICTIVE VALUE OF ERYTHROCYTE ANISOTROPY COEFFICIENT IN PATIENTS HOSPITALIZED FOR ACUTELY DECOMPENSATED CHRONIC HEART FAILURE
by: V. A. Kostenko, et al.
Published: (2017-12-01)

The Comparison of Clinical Characteristics of Acute Decompensated Heart Failure Patients between JCARE-CARD Japan and dr. Kariadi Hospital Registry
by: Mochamad Ali Sobirin, et al.
Published: (2023-05-01)

Hyponatremia predicts immunotherapy resistance in biliary tract cancer
by: Tiance Wang, et al.
Published: (2025-12-01)

IMPACT OF LEVOSIMENDAN ON RENAL FUNCTION IN COMPLEX TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE
by: M. V. Lediakhova, et al.
Published: (2018-05-01)

Early prescription of quadruple therapy in acute decompensated heart failure with reduced ejection fraction: A propensity score‐matched analysis
by: Luis E. Echeverría, et al.
Published: (2025-08-01)

Chlorpromazine-Induced Severe Hyponatremia in 66 Years Old Patient
by: Sri Soenarti, et al.
Published: (2024-01-01)

IMMUNE RESPONSE IN DECOMPENSATED CHRONIC HEART FAILURE OF ISCHEMIC ORIGIN
by: E. V. Kruchinkina, et al.
Published: (2018-03-01)

Effect of dapagliflozin on serum N‐terminal fragment-proB‐type natriuretic peptide level in patient with acute decompensated heart failure
by: Hanna Jassim Dohei, et al.
Published: (2025-03-01)

Allopurinol in the complex therapy of acute decompensation of heart failure
by: Laura H. Sarieva, et al.
Published: (2025-01-01)

Treatment of iron deficiency in patients after acute decompensation: a new target in the treatment of heart failure
by: I. V. Zhirov, et al.
Published: (2022-06-01)